Mehvesh Afrina, M.D.
Child & Adolescent Psychiatry Physician in Plano, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,160 in Child & Adolescent Psychiatry Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mehvesh Afrina, M.D. filed 1,181 Medicare Part D claims in 2023 as a Child & Adolescent Psychiatry Physician in Plano, Texas, prescribing 94% generic.
- 1K
- Part D claims, 2023
- 94%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mehvesh Afrina, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,181 Top 23% higher than 77% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Mehvesh Afrina, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mehvesh Afrina, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Child & Adolescent Psychiatry Physician compares to other specialties among Texas providers
Child & Adolescent Psychiatry Physician ranks #109 among Texas's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Child & Adolescent Psychiatry Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Child & Adolescent Psychiatry Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mehvesh Afrina, M.D. appears in the CMS NPPES registry as a Child & Adolescent Psychiatry Physician provider holding M.D. credentials at 3028 COMMUNICATIONS PKWY STE 300, Plano, TX, 75093, with a listed phone of (972) 473-7444. NPI 1326215047 was issued on 05/12/2008.
Medicare Part D records for calendar year 2023 show 1,181 prescription claims written by this provider, covering 77 Medicare beneficiaries and totaling roughly $68K in drug spend, split 6% brand-name and 94% generic by claim count.
Child & Adolescent Psychiatry Physician is a mid-sized specialty nationwide, with 6,160 enrolled providers across 54 states and an average of 600 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1326215047 |
|---|---|
| Specialty | Child & Adolescent Psychiatry Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/12/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mehvesh Afrina, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1326215047 is the unique 10-digit identifier CMS uses to link Afrina across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Mehvesh Afrina, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mehvesh Afrina, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Corium, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Mehvesh Afrina, M.D.. To verify Mehvesh Afrina, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
6% brand-name claims vs 94% generic, on 1,181 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,332
- Total Day Supply
- 38,041
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $42K
- Generic Drug Cost
- $26K
Patient Demographics
- Average Patient Age
- 63.9 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 32, 65-74: 31, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mehvesh Afrina, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Bupropion Xl
Bupropion Xl
105 claims
- Clonazepam
Clonazepam
96 claims
- Trazodone Hcl
Trazodone Hcl
94 claims
- Dextroamphetamine-…
Dextroamphetamine-Amphetamine
54 claims
- Alprazolam
Alprazolam
52 claims
- Aripiprazole 40
Aripiprazole
40 claims
- Lorazepam 40
Lorazepam
40 claims
- Buspirone Hcl 39
Buspirone Hcl
39 claims
| Drug | Claims |
|---|---|
| Bupropion Xl Bupropion Hcl | 105 |
| Clonazepam | 96 |
| Trazodone Hcl | 94 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 54 |
| Alprazolam | 52 |
| Aripiprazole | 40 |
| Lorazepam | 40 |
| Buspirone Hcl | 39 |
| Fluoxetine Hcl | 38 |
| Methylphenidate Hcl | 36 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Child & Adolescent Psychiatry Physician Overview
How Mehvesh Afrina, M.D. fits within the Child & Adolescent Psychiatry Physician landscape nationally.
Mehvesh Afrina, M.D.'s 1,181 claims are above the specialty average of 600.
Nearby Child & Adolescent Psychiatry Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Afrina.
Compare Child & Adolescent Psychiatry Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Child & Adolescent Psychiatry Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Mehvesh Afrina, M.D.'s specialty? ▼
How much does Mehvesh Afrina, M.D. prescribe under Medicare Part D? ▼
Where is Mehvesh Afrina, M.D. located? ▼
What is Mehvesh Afrina, M.D.'s NPI number? ▼
Does Mehvesh Afrina, M.D. prescribe more brand-name or generic drugs? ▼
How many Child & Adolescent Psychiatry Physician providers are there in the US? ▼
What drugs does Mehvesh Afrina, M.D. prescribe most often? ▼
Does Mehvesh Afrina, M.D. accept Medicare? ▼
How can I verify Mehvesh Afrina, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology